510(k) Report

510(k) · Cleared

Cleared

Flostat Vascular Lab

K973644510(k) TraditionalCleared Dec 23, 199790-day reviewClass II21 CFR 892.1540

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Biomedix, Inc. · JAF Monitor, Ultrasonic, Nonfetal

Cleared on Dec 23, 1997 after a 90-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 7 later devices descend from it.

Decided
Dec 23, 1997
Review
90 days
Class
Class II
Product code
JAF
Recalls
None
Predicates
0

7 later devices descend from it, 3 citing it directly.

Descendants, by year cleared 2004: 1 descendant cleared2007: 1 descendant cleared2001: 1 descendant cleared2010: 1 descendant cleared2011: 1 descendant cleared2012: 1 descendant cleared2022: 1 descendant cleared1995200020052010201520202025
  1. This deviceK973644 Flostat Vascular LabBiomedix, Inc. · 1997
  2. Descendant · cites it directly · 5 of its ownK042616 Biomedix Padnet LabBiomedix, Inc. · 2004
  3. Descendant · cites it directly · 2 of its ownK073146 Padnet+Biomedix, Inc. · 2007
  4. Descendant · 2 generations on · 1 of its ownK122281 Padnet 2.0Biomedix, Inc. · 2012
  5. Descendant · 3 generations on · 0 of its ownK220527 PADnet XpressCollaborative Care Diagnostics, LLC, D.B.A. Biomedix · 2022
  6. Descendant · 2 generations on · 0 of its ownK103693 Vantage AbiSummit Doppler Systems, Inc. · 2011

Showing 5 of 7 descendants. See all descendants

Descendants cleared per year

2001: 12004: 12007: 12010: 12011: 12012: 12022: 1
2001high 1 (2001) · low 0 (2002)2026

Most influential descendants

Showing 5 of 7 · See all
  • K042616Biomedix Padnet LabBiomedix, Inc. · 2004 · cites it directly5descendants
  • K073146Padnet+Biomedix, Inc. · 2007 · cites it directly2descendants
  • K122281Padnet 2.0Biomedix, Inc. · 2012 · 2 generations on1descendant
  • K220527PADnet XpressCollaborative Care Diagnostics, LLC, D.B.A. Biomedix · 2022 · 3 generations on0descendants
  • K103693Vantage AbiSummit Doppler Systems, Inc. · 2011 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K973644Flostat Vascular LabBiomedix, Inc.1997—
+1K042616Biomedix Padnet LabBiomedix, Inc.2004—
+1K073146Padnet+Biomedix, Inc.2007—
+2K122281Padnet 2.0Biomedix, Inc.2012—
+3K220527PADnet XpressCollaborative Care Diagnostics, LLC, D.B.A. Biomedix2022—
+2K103693Vantage AbiSummit Doppler Systems, Inc.2011—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200110
200410
200710
201010
201110
201210
202210
FIG. 1 — Lineage of K973644, 1997–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JAF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JAF device

  1. #1 K242487 Laminar P1 (LDH-HW-001)score 10.3 · 7 generations · no Class I recall
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it? (7)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K042616Biomedix Padnet LabBiomedix, Inc.20045
K073146Padnet+Biomedix, Inc.20072
K012369Basic, Models Basic 1, Basic 2, and Basic 3Atys Medical20010

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K042616 (Biomedix, Inc., 2004) has gone furthest, with 5 descendants of its own.

How does its category compare?

All JAF devices

JAF Monitor, Ultrasonic, Nonfetal: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · JAF

1in 2024

2007: 12008: 12009: 22011: 12015: 12024: 1
2007high 2 (2009) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JAF

Too few JAF 510(k)s in any year since 2007 to give a median.

Recalls per year · JAF

No recall names JAF since 2007.

Adverse event reports per year · JAF

1in 2023

2010: 12012: 12013: 22014: 82015: 72016: 52017: 442018: 12019: 22020: 52021: 12022: 22023: 1
2007high 44 (2017) · low 0 (2007)2025

MAUDE reports naming product code JAF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20081—00
20092—00
20100—01
20111—00
20120—01
20130—02
20140—08
20151—07
20160—05
20170—044
20180—01
20190—02
20200—05
20210—01
20220—02
20230—01
20241—00
20250—00
20260—0—

What is it indicated for?

The BioMedix, Inc. Flostat Vascular Lab is a device for the use in the diagnosis of the etiology and extent of vascular pathology primarily in the peripheral vasculature and, in a more restricted sense, in the central vasculature (periorbital region ONLY). These tasks are accomplished via three separate modalities, each of which can be use to test either the arterial or venous system. The three modalities are 1) Pneumoplethysmography (blood pressure cuff…

Read the full statement (475 words)

The BioMedix, Inc. Flostat Vascular Lab is a device for the use in the diagnosis of the etiology and extent of vascular pathology primarily in the peripheral vasculature and, in a more restricted sense, in the central vasculature (periorbital region ONLY). These tasks are accomplished via three separate modalities, each of which can be use to test either the arterial or venous system. The three modalities are 1) Pneumoplethysmography (blood pressure cuff air inflation), 2) Photoplethysmography (change in infrared light reflectance on skin as a reflection of larger branches) and 3) Simple continuous wave doppler ultrasound velocity waveform measurement. NONE of these testing modalities are intended for FETAL USE and the devices and instruction manuals are so labelled.

The air pump Pneumoplethysmograph and infrared Photoplethysmograph are for use in studying the PERIPHERAL VASCULATURE ONLY.

The 5 MHz. continuous wave doppler ultrasound velocity meter and the 8 MHz. continuous wave doppler ultrasound velocity meter are for use in studying the PERIPHERAL VASCULATURE ONLY.

There is a separate control setting labelled clearly on the FLOSTAT VASCULAR LAB - ‘Ophthalmic-8 MHz.’ doppler which is intended for periorbital doppler studies ONLY. The ‘Ophthalmic-8 MHz.’ mode is an 8 MHz. continuous wave doppler ultrasound velocity meter exactly the same as the 8 MHz. continuous wave doppler velocity meter except that the ‘Ophthalmic-8 MHz.’ doppler has substantially lower acoustic output which conforms to the safety standards for periorbital studies specified by the Food and Drug Administration (FDA). Through medical studies performed by the scientists at the FDA, it has been determined that ultrasound acoustic levels as rated by various figures of merit (eg ISPTA, etc.) are safe for different areas of the body.

For this reason, DO NOT EVER PERFORM PERIORBITAL STUDIES WITH THE DOPPLER IN ANY MODE OTHER THAN THE ‘Ophthalmic-8 MHz.’ MODE. Labels will also be placed on the doppler transducer that they are NOT FOR FETAL USE and specifying the correct frequency (5 MHz or 8 MHz).

The doppler section is intended to generate velocity waveforms and values for study and audio output for physician analysis of the arterial and venous system.

The Ultrasonic Doppler device at 5 MHz. and 8 MHz. applies ultrasound energy through the extremities of the subject to assess blood velocity, blood velocity waveform morphology, spectrum analysis, pressure, and patency of PERIPHERAL VESSELS.

The Ultrasonic Ophthalmic-8 MHz. device applies ultrasound energy to the periorbital region to assess blood velocity, blood velocity waveform morphology, and spectrum analysis in this area.

The Pneumoplethysmograph is used to gauge the arterial system through volume pulse recording studies and is used to gauge the venous system through maximum venous outflow studies.

The Photoplethysmograph is used to gauge the arterial system through pulse waveform analysis and is used to gauge the venous system through venous reflux time tests. Full clinical information is provided in the Operators Instruction Manual (enclosed herein).

Indications for use read by OCR from a scanned FDA 510(k) statement, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K973644: Flostat Vascular Lab.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K973644

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026